您好,欢迎来到科研在线!科研采购 · 选型 · 实验方法
首页产品库品牌馆产品类别品牌新闻会议会展产品试用求职招聘资讯专题教程
REA / Bioactive Compounds

Recombinant Human VEGF-165 Protein

Recombinant Human VEGF-165 Protein

英诺赛图(InnoCyto)的 Recombinant Human VEGF-165 Protein,属于生物活性物质,靶点/物种 VEGFA165(别名 VEGFA 等),表达宿主 HEK293,纯度 ≥95%(SDS-PAGE),适用于生物活性检测。提供 20 µg、100 µg、500 μg 规格,目录价 ¥2,000 起,仅供科研使用(RUO)。

科学仪器 供应商 上海英诺赛图 ↗ 型号 631001 更新 2026-11-12
参考价格区间
¥2,000
含税参考价,实际以配置与渠道报价为准
本条目供应商 上海英诺赛图原厂 1865个条目 进入企业主页

01产品图片

02产品简介

英诺赛图(InnoCyto)的 Recombinant Human VEGF-165 Protein,属于生物活性物质,靶点/物种 VEGFA165(别名 VEGFA 等),表达宿主 HEK293,纯度 ≥95%(SDS-PAGE),适用于生物活性检测。提供 20 µg、100 µg、500 μg 规格,目录价 ¥2,000 起,仅供科研使用(RUO)。

03产品介绍

规格与货号

631001 | 20 µg | ¥2,000

631002 | 100 µg | ¥4,136

631003 | 500 μg | ¥9,831

Product Details

Sources|A DNA sequence encoding the human / cynomolgus VEGF165 isoform (P15692-4) (Met1-Arg191) was expressed. Human and Cynomolgus VEGF165 sequences are identical.

Molecular Weight|The recombinant human / cynomolgus VEGF165 consists of 165 amino acids and predicts a molecular mass of 19.2 KDa. It migrates as an approximately 22 kDa and 24 kDa band in SDS-PAGE under reducing conditions.

Regulatory Status|RUO

Endotoxin level

Protein Concentration|Lyophilized

Storage and Handling|Proteins are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.

Background Information

Human vascular endothelial growth factor 165 (VEGF-165) is a major pro-angiogenic isoform of VEGF-A that plays a central role in blood vessel formation, vascular permeability, and endothelial cell survival. It is particularly important in both physiological processes such as wound healing and embryonic vascular development, and in pathological angiogenesis associated with disease. VEGF-165 is the most abundant and biologically active splice variant of VEGF-A, distinguished by its intermediate size and strong heparin-binding capacity, which influences its distribution in extracellular matrices.

Structurally, VEGF-165 is a disulfide-linked homodimer composed of two identical subunits, each contributing to receptor binding and dimer stabilization. The protein contains distinct domains, including a receptor-binding domain and a heparin-binding domain encoded by the inclusion of exon 7 in its splice form. This structural feature enhances its interaction with extracellular matrix components and co-receptors. VEGF-165 primarily binds to VEGF receptor tyrosine kinases VEGFR-1 (FLT1) and VEGFR-2 (KDR), with VEGFR-2 being the dominant mediator of angiogenic signaling. It can also interact with co-receptors such as neuropilins (NRP1/NRP2), which enhance signaling potency.

VEGF-165 does not have multiple classical ligands; rather, it functions as a ligand itself within the VEGF-A family isoforms. Dysregulation of VEGF-165 expression is strongly implicated in cancer, diabetic retinopathy, age-related macular degeneration, and other disorders characterized by abnormal vascular growth or permeability. Therapeutically, VEGF-165 is a major target of anti-angiogenic strategies, including monoclonal antibodies, receptor decoys, and small-molecule inhibitors. Conversely, controlled delivery of VEGF-165 has been investigated for promoting therapeutic angiogenesis in ischemic heart disease and peripheral vascular disease.

Data Sheets

Cat # Size Price Quantity 63100120 µg Add to Cart631002100 µg Add to Cart631003500 μg Add to Cart

04完整参数表

参数由厂商资料整理,采购前请以最终报价单与技术协议为准。

包装规格20 µg
ApplicationBioassay
FormatLyophilized from sterile 20mM Tris, 150mM NaCl, pH 8.0
Expression HostHEK293
Target NameVEGFA165, VEGFA, MVCD1, VEGF, Vascular permeability factor (VPF)
SpeciesHuman
accession numberP15692-4
Affinity TagNone
Purity≥ 95 % as determined by SDS-PAGE. ≥ 95 % as determined by SEC-HPLC.
Regulatory StatusRUO
Protein ConcentrationLyophilized
目录价¥2,000

05荣誉与资质

该品牌暂未上传荣誉证书与资质文件。以下是平台可核验的公开信息,未上传项如实标注,不做推断。

  • 营业执照未上传
  • 品牌授权未上传
  • 产品检测报告未上传
会员身份
收费会员
经营身份
原厂
成立年份
2020 年
所在地
上海
收录条目
1865 个
平台核验
平台代管
向品牌方索取资质文件

06品牌与供应商

上海英诺赛图 原厂
InnoCyto

以可信赖的细胞研究试剂,助力科研突破

进入企业主页
1865 本目录条目
产地 / 总部上海市浦东新区
成立年份2020 年
本目录主营生化试剂 / 蛋白与抗体

InnoCyto(上海英诺赛图生物科技有限公司)致力于通过开发高质量细胞分析试剂,加速科学发现进程。公司为研究人员提供细胞层面探索所需的工具,推动免疫学、肿瘤学等多领域的研究创新。 核心团队拥有丰富的行业经验,曾参与全球头部生命科学公司的标杆项目搭建,深刻理解工业界与学术研究的前沿需求。试剂从设计之初即以精确性、一致性、高性能为核心标准,让科学家能把精力集中在最核心的研究工作上。 公司将深厚的科学积累与对品质的严格承诺相结合,力争成为全球研究人员信赖的合作伙伴。产品线覆盖经验证的一抗与二抗、同型对照、生物类似药抗体、重组蛋白、细胞因子、免疫检测试剂盒及配套试剂,并提供重组蛋白/抗体表达与标记偶联服务。

售后与服务

品牌资料由厂商公开信息与授权渠道核对整理;条目参数与价格以最终报价单为准。

引用此条目 产品目录 · 更新于 2026-11-12
科研在线(TeleVM). Recombinant Human VEGF-165 Protein(631001)[EB/OL]. 产品目录, 2026-11-12. https://www.suprotek.cn/products/item/recombinant-human-vegf-165-protein.html.
TeleVM. (2026, November 12). Recombinant Human VEGF-165 Protein(631001). 产品目录. https://www.suprotek.cn/products/item/recombinant-human-vegf-165-protein.html
@misc{biocsp_item_recombinant_human_vegf_165_protein,
  title        = {Recombinant Human VEGF-165 Protein(631001)},
  author       = {{科研在线}},
  year         = {2026},
  howpublished = {产品目录},
  note         = {更新于 2026-11-12,产品目录},
  url          = {https://www.suprotek.cn/products/item/recombinant-human-vegf-165-protein.html}
}

GB/T 7714 用于中文论文与报告;APA 7 用于英文期刊;BibTeX 可直接导入 Zotero、EndNote 或 LaTeX。

许可:CC BY-NC 4.0 · 转载注明来源
获取正式报价

Recombinant Human VEGF-165 Protein

提交后由平台转给品牌方,通常 1 个工作日内联系。不需要注册。